Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns
Shares of Fulcrum Therapeutics plunged 50% in premarket trading on Tuesday after the company said it would abandon development of its experimental sickle-cell disease drug following
June 02, 2026
Postal Service won’t deliver mail ballots for states that don’t hand over voter lists, under plan for Trump directive
Ukraine launches long-range strikes on military and energy sites in Russia
Global watchdog calls for tighter controls on agentic AI in finance
Pope honors Barcelona's sacred monuments on death centenary of Sagrada Familia designer Gaudí
US Catholic bishops are consecrating the nation to the Sacred Heart of Jesus. Here's what that means
Indonesia swallows 'bitter pill' to stem market rout as policy tide turns
Tyler Mane, ‘X-Men’ star and former pro wrestler, says he has ‘super-rare’ breast cancer
Pope Leo puts focus on prisoners in first papal visit to a Spanish jail